Apimeds Pharmaceuticals US, Inc.
APUS
$2.27
$0.4625.41%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -402.40K | -311.60K | -332.50K | -449.40K |
| Total Depreciation and Amortization | 200.00 | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.91M | 38.00K | 36.10K | 32.60K | 22.10K |
| Change in Net Operating Assets | -2.60M | 344.10K | 176.00K | 113.10K | 243.20K |
| Cash from Operations | -3.36M | -20.30K | -99.60K | -186.80K | -184.10K |
| Capital Expenditure | -13.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.40K | -- | -- | -- | -- |
| Total Debt Issued | 200.00 | 267.20K | 76.50K | 150.00K | 100.00K |
| Total Debt Repaid | -93.80K | -- | -- | -- | -- |
| Issuance of Common Stock | 11.95M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.86M | 267.20K | 76.50K | 150.00K | 100.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.49M | 246.90K | -23.10K | -36.80K | -84.10K |